Optibiotix Health Overview
- Founded
-
2012
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
OPTI
- Investments
-
2
- Share Price
-
$0.14
- (As of Friday Closing)
Optibiotix Health General Information
Description
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
LON
Primary Office
- Innovation Centre
- Innovation Way, Heslington
- York YO10 5DG
- England, United Kingdom
Optibiotix Health Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.14 | $0.14 | $0.13 - $0.55 | $12.5M | 91.2M | 109K | $0.09 |
Optibiotix Health Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2018 30-Nov-2018 |
|---|---|---|---|---|
| EV | 20,342 | 54,382 | 68,669 | 98,864 |
| Revenue | 1,670 | 3,043 | 1,953 | 689 |
| EBITDA | 8,110 | 8,956 | 7,695 | (2,419) |
| Net Income | 7,856 | 8,610 | 7,437 | (2,572) |
| Total Assets | 27,251 | 27,188 | 18,675 | 10,263 |
| Total Debt | 0 | 1,106 | 1,052 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Optibiotix Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Optibiotix Health Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in research
Biotechnology
York, United Kingdom
3
As of 2021
00.000
000000000
00.000
000000
e dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla p
0000 000000000
South San Francisco, CA
00
As of 0000
00000
0000
0000-00-00
00000000000
00000
00000
liquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
0000000000000
Cambridge, MA
000
As of 0000
00000
000000000
00000
Add Comparison
Optibiotix Health Competitors (49)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neuron23 | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 00000000000 | 00000 |
| 00000 000000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000000 | 00000 |
| 0000 000000 | Formerly VC-backed | Lyon, France | 00 | 000.00 | 00000000 | 000.00 |
| 0000 0000000000000 | Formerly VC-backed | Seattle, WA | 000 | 00.000 | 00000000 | 00.000 |
| 00000 00000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000000 | 00000 |
Optibiotix Health Patents
Optibiotix Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-2563321-A | Method of configuring a radar track analyser and configuration apparatus | Active | 29-Apr-2016 | 000000000 | |
| GB-2563321-B | Method of configuring a radar track analyser and configuration apparatus | Active | 29-Apr-2016 | 000000000 | 0 |
| GB-201805580-D0 | Method of configuring a radar track analyser and configuration apparatus | Active | 29-Apr-2016 | G06T7/254 |
Optibiotix Health Executive Team (8)
Optibiotix Health Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Adam Reynolds | Optibiotix Health | Non-Executive Chairman | 000 0000 |
| Per Rehne | Optibiotix Health | Board Member | 000 0000 |
| Sofia Kolyda | Optibiotix Health | Board Member | 000 0000 |
| Stephen O'Hara | Optibiotix Health | Founder & Chief Executive Officer | 000 0000 |
Optibiotix Health Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Optibiotix Health Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Optibiotix Health Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 0000000 0 | 26-Jul-2016 | 0000000000 | 0000 | Food Products | 0000000 0 |
| Ducat Ventures | 18-Jul-2014 | Merger/Acquisition | 00.000 | Other Commercial Products |
Optibiotix Health ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
